MSFT vs NKE: Which Is the Better Buy?

Side-by-side comparison of Microsoft Corporation and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
Microsoft Corporation Β· Technology
$372.20
+32.4% upside to fair value
High Conviction Grade A
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+45.5%). MSFT trades at a lower forward P/E (22.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MSFT NKE
Current Price $372.20 $42.62
Fair Value Estimate $493.00 $62.00
Upside to Fair Value +32.4% +45.5%
Market Cap $2,763.6B $63.0B
Forward P/E 22.0x 27.9x
EV / EBITDA 17.5x 20.7x
Price / Sales 9.1x 1.4x
Price / FCF 35.8x 19.4x
Revenue Growth YoY +14.9% -9.8%
Gross Margin 68.8% 42.7%
Operating Margin 45.6% 8.0%
Return on Equity 29.6% 24.4%
Dividend Yield 0.94% 3.8%
FCF Yield 2.8% 5.2%
Analyst Consensus Strong Buy Buy
Investment Thesis
MSFT β€” Microsoft Corporation
Microsoft is the world's largest software company, operating a three-pillar empire across cloud (Azure), productivity (Office 365/Teams), and personal computing (Windows/Xbox). Azure is the second-largest cloud platform globally with 24% market share and growing at 38-39% in constant currency, while Microsoft Cloud revenue crossed $168.9B in FY2025. The stock has dropped 33% from its highs to $37…
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric MSFT NKE
Zone Low $370.00 $44.00
Zone High $419.00 $50.00
In Buy Zone? Yes Yes
← MSFT Research    NKE Research β†’    All Research